These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14509754)

  • 1. [Management of recombinant growth hormone treatment in Prader-Willi syndrome].
    Tauber M
    Arch Pediatr; 2003 May; 10 Suppl 1():90s-91s. PubMed ID: 14509754
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations for the clinical use of recombinant human growth hormone in children].
    ; ; ; ;
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):426-32. PubMed ID: 24120059
    [No Abstract]   [Full Text] [Related]  

  • 3. POI: a score to modulate GH treatment in children with Prader-Willi syndrome.
    Salvatoni A; Berini J; Chiumello G; Crinò A; Di Candia S; Gargantini L; Grugni G; Iughetti L; Luce A; Musolino G; Sogno Valin P; Spica Russotto V; Trifirò G
    Horm Res Paediatr; 2012; 78(3):201-2. PubMed ID: 22986481
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth hormone therapy in the Prader-Willi syndrome.
    Paterson WF; Donaldson MD
    Arch Dis Child; 2003 Apr; 88(4):283-5. PubMed ID: 12651746
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.
    Sipilä I; Sintonen H; Hietanen H; Apajasalo M; Alanne S; Viita AM; Leinonen E
    Acta Paediatr; 2010 Nov; 99(11):1712-8. PubMed ID: 20545932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone treatments and cognitive functioning in children with Prader-Willi syndrome.
    Deal CL; Rogol AD
    Eur J Endocrinol; 2020 Jun; 182(6):C21-C25. PubMed ID: 32240979
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
    J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index in children with Prader-Willi Syndrome during human growth hormone therapy: a real world situation.
    Dewan T; Chanoine JP
    J Pediatr; 2009 May; 154(5):777-8; author reply 779. PubMed ID: 19364570
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth hormone and respiratory compromise in Prader-Willi Syndrome.
    Wilson SS; Cotterill AM; Harris MA
    Arch Dis Child; 2006 Apr; 91(4):349-50. PubMed ID: 16551791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone therapy for short stature: is the benefit worth the burden?
    Allen DB
    Pediatrics; 2006 Jul; 118(1):343-8. PubMed ID: 16818584
    [No Abstract]   [Full Text] [Related]  

  • 11. Sleep-related breathing disorders in patients with Prader-Willi syndrome depending on the period of growth hormone treatment.
    Lecka-Ambroziak A; Jędrzejczak M; Wysocka-Mincewicz M; Szalecki M
    Endokrynol Pol; 2017; 68(6):676-681. PubMed ID: 29022650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukemia in a patient with Prader-Willi syndrome under growth hormone therapy.
    Kato M; Mugishima H; Chin M; Urakami T; Harada K
    Pediatr Int; 2005 Jun; 47(3):336-7. PubMed ID: 15910463
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone: the expansion of available products and indications.
    Franklin SL; Geffner ME
    Pediatr Clin North Am; 2011 Oct; 58(5):1141-65, x. PubMed ID: 21981953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.
    Deal CL; Tony M; Höybye C; Allen DB; Tauber M; Christiansen JS;
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1072-87. PubMed ID: 23543664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment in a girl with Prader Willi syndrome.
    Pandey SN; Vaidya RA; Irani A
    Indian J Pediatr; 2003 Apr; 70(4):351-3. PubMed ID: 12793314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee.
    Wilson TA; Rose SR; Cohen P; Rogol AD; Backeljauw P; Brown R; Hardin DS; Kemp SF; Lawson M; Radovick S; Rosenthal SM; Silverman L; Speiser P;
    J Pediatr; 2003 Oct; 143(4):415-21. PubMed ID: 14571209
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth hormone prescribing patterns in the UK, 2013-2016.
    Shepherd S; Saraff V; Shaw N; Banerjee I; Patel L
    Arch Dis Child; 2019 Jun; 104(6):583-587. PubMed ID: 30567827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIGS highlights: growth hormone treatment in Prader-Willi Syndrome.
    Tauber M; Cutfield W
    Horm Res; 2007; 68 Suppl 5():48-50. PubMed ID: 18174707
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth hormone therapy in children with Prader-Willi syndrome.
    Franzese A; Romano A; Spagnuolo MI; Ruju F; Valerio G
    J Pediatr; 2006 Jun; 148(6):846; author reply 846-7. PubMed ID: 16769405
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
    Ritzén EM; Lindgren AC; Hagenäs L; Marcus C; Müller J; Blichfeldt S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():345-9. PubMed ID: 10698600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.